HeartMate Touch
Device Heart failure
PDI 05415067033758
General payments
$457,425
Research payments
$3,654
Through program year 2024, $457,425 in general payments and $3,654 in research payments were reported against HeartMate Touch (Heart failure).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $191 | 11 |
| 2023 | General | $7,560 | 101 |
| 2022 | General | $71,980 | 1,064 |
| 2021 | General | $377,693 | 1,632 |
| 2021 | Research | $3,654 | 1 |
Breakdown
The top 5 of 11 recipients; each share is of general payments naming this product in 2024.
The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2024 where a state was reported.
Records
2,808 general · 1 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.